3Beutner KR,Tyring SK,Trofatter KF Jr,et al.Imiquimod,a patient-applied immune-response modifier for treatment of external genital warts[J].Antimicrob Agents Chemother,1998,42 (4):789-794.
4Edwards L,Ferenczy A,Eron L,et al.Self-administered topical 5% imiquimod cream for external anogenital warts.HPV Study Group.Human Papilloma Virus[J].Arch Dermatol,1998,134 (1):25-30.
5Sauder DN,Skinner RB,Fox TL,et al.Topical imiquimod 5% cream as an effective treatment for external genital and perianal warts in different patient populations[J].Sex Transm Dis,2003,30 (2):124-128.
6Syed TA, Ahmadpour OA, Ahmad SA, et al. Management of toenail onychomycosis with 2% butenafine and 20% urea cretan: a placebo-controlled, double-blind study. J Dermatol, 1998 , 25: 648-652.
7Perry CM, Lamb HM. Topical imiquimod: a review of its use in genital warts. Drugs, 1999 , 58: 375-390.
8Edwards L, Ferenczy A, Eron L, et al. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus. Arch Dermatol, 1998, 134: 25-30.
9Beutner KR, Spruance SL, Hougham AJ, et al. Treatment of genital warts with an immune-response modifier (imiquimod). J Am Acad Dermatol, 1998, 38(2 Pt 1 ): 230-239.
